RECENT NEWS

North Bristol NHS Trust and Fujifilm Healthcare Europe are to continue their long-standing relationship, with the establishment of a reference site agreement for the UK featuring the Synapse Pathology solution to support Bristol’s innovative histology practice.

Researchers at Amsterdam University Medical Center (UMC) have taken a big step towards a vaccine for HIV after its first in-human assessment of germline-targeting strategy with a trimer displays positive results.

The Microbiology Society, together with the British Mycological Society, has announced Dr Harry Chown of Imperial College London, UK, as the winner of the 2025 Tony Trinci Award.

Becton Dickinson (BD) has announced the global commercial launch of the world's first cell analyser featuring breakthrough spectral and real-time cell imaging technologies.

A research team at the Korea Institute of Machinery and Materials (KIMM) has developed a compact, rapid pretreatment system capable of liquefying and homogenising solid biological samples in under one minute.

New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment for hormone-sensitive prostate cancer patients.

The Department of Health and Social Care (DHSC) has appointed four experienced executive business leaders to strengthen partnerships with strategic suppliers to health.

Roche has announced plans to invest up to US $550 million in its diagnostics manufacturing site in Indianapolis by 2030.

The new headquarters of UK Biobank, a £60m state-of-the-art laboratory and innovation hub at Manchester Science Park called Greenheys, recently celebrated an important milestone, ‘topping out’ the new building.

A single blood test, designed to pick up chemical signals indicative of the presence of many different types of cancer, could thwart progression to advanced disease while the malignancy is still at an early stage and amenable to treatment in up to half of cases, suggests a new study.

Leica Microsystems has launched the Visoria series of upright microscopes, to help enhance the efficiency and comfort of routine microscopy work for pathologists, quality control managers, and researchers.

Histofy, a leading UK-based pathology AI company focused on accelerating histopathology workflows in both clinical and pharmaceutical sectors, has announced a strategic partnership with Source BioScience UK Limited, the largest histopathology service provider in the United Kingdom.

Chemists at Massachusetts Institute of Technology (MIT) have found a way to identify a complex sugar molecule in the cell walls of the bacteria that cause tuberculosis.

Genomics England has announced the appointment of Julian Thomas into the new role of Chief Technology and Product Officer.

The UK government has unveiled details of a new tool which it says will speed up cancer diagnosis and treatment, as part of its major reform to the NHS.

A new report published by the UK Health Security Agency (UKHSA) shows current state of health inequalities in England caused by infectious diseases, as well as environmental health hazards.

Molecular diagnostics firm Seegene has revealed some details of its forthcoming CURECA automated PCR system following its recent launch at the European Society of Clinical Microbiology and Infectious Diseases in Vienna, Austria.

Roche has announced the launch of its Elecsys PRO-C3 test, a new diagnostic solution designed to assess the severity of liver fibrosis in patients showing signs of metabolic dysfunction–associated steatotic liver disease (MASLD).

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a vaccine (Vimkunya) used to prevent disease caused by the chikungunya virus in people 12 years of age and older.

Plans to create the London Cancer Hub, set to be the world’s leading district for cancer research and treatment submitted to Sutton Council. Once built the new centre will create thousands of jobs and contribute £1.2 billion to the UK economy.